Piramal Pharma Ltd
NSE: PPLPHARMA BSE: 543635
₹237.76
+4.07 (1.74%)
Sat, 07 Nov 2026, 07:37 pm
Market Cap (in Cr)31133.58
PE Ratio0
Dividend0.06
Health Technology
Pharmaceuticals: Major
24.5KPiramal Pharma Income Statement
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total revenue | 65.59B | 70.82B | 81.71B | 91.46B |
| Gross profit | 13.80B | 10.98B | 16.78B | 19.59B |
| Operating expenses (excl. COGS) | -10.07B | -11.34B | -11.58B | -12.58B |
| Selling/general/admin expenses, total | -9.33B | -10.77B | -11.16B | -11.63B |
| Research & development | -1.28B | -863.60M | -1.01B | -1.44B |
| Selling/general/admin expenses, other | -8.05B | -9.90B | -10.16B | -10.20B |
| Other operating expenses, total | -734.40M | -571.70M | -420.20M | -945.10M |
| Operating income | 3.74B | -359.80M | 5.20B | 7.01B |
| Non-operating income, total | 523.10M | -1.39B | -4.00B | -3.59B |
| Interest expense, net of interest capitalized | -1.98B | -3.44B | -4.45B | -4.21B |
| Interest capitalized | 0 | 0 | 108.40M | 0 |
| Non-operating income, excl. interest expenses | 2.06B | 1.64B | 1.08B | 1.08B |
| Non-operating interest income | 6.80M | 16.40M | 111.00M | 103.80M |
| Miscellaneous non-operating expense | 2.05B | 1.62B | 969.10M | 924.40M |
| Unusual income/expense | 450.50M | 420.40M | -627.90M | -460.00M |
| Pretax income | 4.26B | -1.74B | 1.20B | 3.42B |
| Taxes | -1.09B | -663.10M | -1.61B | -3.24B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 3.76B | -1.86B | 178.20M | 911.30M |
| Net income | 3.76B | -1.86B | 178.20M | 911.30M |
| Dilution adjustment | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 3.76B | -1.86B | 178.20M | 911.30M |
| Basic earnings per share (Basic EPS) | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - |
| EBITDA | 9.60B | 6.41B | 12.60B | 15.17B |
| EBIT | 3.74B | -359.80M | 5.20B | 7.01B |
| Total operating expenses | -61.85B | -71.18B | -76.51B | -84.45B |
| Prepaid expenses | 695.50M | 765.70M | 652.60M | 791.80M |
| Deferred income, current | 1.85B | 2.01B | 3.44B | 2.23B |
| Capital and operating lease obligations | 862.00M | 1.02B | 1.18B | 991.60M |
| Operating lease liabilities | — | — | — | — |
| Deferred tax liabilities | 3.01B | 3.35B | 4.43B | 4.68B |
| Deferred income, non-current | 1.50B | 1.57B | 1.44B | 1.46B |
| Minority interest | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — |
| Common dividends paid | -500.00M | -670.00M | 0 | -144.70M |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
